AngioDynamics, which reported declining fiscal 3rd-quarter sales and earnings, said it's getting back into embolization with a licensing deal for EmboMedics' microspheres.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1D3Qy1O
Cap comentari:
Publica un comentari a l'entrada